DoD Peer Reviewed Cancer, Idea Award
ID: 353914Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 1, 2024, 12:00 AM UTC
  4. 4
    Due Sep 26, 2024, 12:00 AM UTC
Description

The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Research Program (PRCRP) Idea Award, aimed at advancing innovative cancer research relevant to military personnel, veterans, and their families. This grant supports high-risk, untested concepts that challenge existing paradigms in cancer research, with a focus on enhancing patient care and treatment options within the Military Health System. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a maximum of two years. Interested applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

Point(s) of Contact
Files
Title
Posted
Aug 24, 2024, 2:22 AM UTC
The Department of Defense (DOD) is offering the FY24 Peer Reviewed Cancer Research Program (PRCRP) Idea Award, aiming to enhance cancer research relevant to military personnel, veterans, and their families. With an appropriation of $130 million for FY24, this initiative focuses on innovative and untested research concepts with potential high impact. Applications must address congressionally directed topic areas excluding certain cancers and align with defined Military Health Focus Areas to enhance mission readiness. Submissions are due in two phases: a pre-application by June 21, 2024, and a full application by September 26, 2024. The awards will fund specific projects up to $400,000 for a maximum of two years, with expectations for collaborative efforts and innovative approaches that challenge existing methods. The selection process involves a peer review stage followed by a programmatic review for alignment with DOD priorities. The ultimate goal is to decrease the cancer burden on military personnel and improve overall health outcomes. This grant opportunity showcases the DOD’s commitment to addressing unique health challenges faced by service members and their families through targeted research initiatives.
Similar Opportunities
DOD Ovarian Cancer, Investigator-Initiated Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award for fiscal year 2025. This grant aims to support innovative research that addresses critical needs in ovarian cancer care, with a focus on areas such as ovarian cancer biology, novel therapies, prevention strategies, early detection, and enhancing patient survivorship. The program is significant for advancing ovarian cancer research and improving care for service members and the broader community. Interested applicants can submit a pre-application by June 12, 2025, with full applications due by September 11, 2025. The estimated total program funding is $8,050,000, with individual awards up to $1.05 million for single Principal Investigators and $1.4 million for partnering PIs, and preliminary data is required to demonstrate the scientific validity of the proposed research. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
DoD Breast Cancer Breakthrough Award Level 3
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. Applicants are required to address at least one of the Department of Defense-defined challenges related to breast cancer, and the research team must include breast cancer consumer advocates to ensure patient perspectives are integrated into the research process. This grant program allocates approximately $27.9 million for three awards, with funding caps of $4 million for single Principal Investigators and $5 million for projects involving a Partnering PI. Pre-applications are due by June 13, 2025, and full applications must be submitted by September 10, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DOD Ovarian Cancer, Pilot Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Ovarian Cancer Research Pilot Award, aimed at fostering innovative research in ovarian cancer. This grant opportunity encourages projects that explore groundbreaking concepts and approaches to enhance early detection and prevention strategies, with a focus on significant advancements that can impact patient care. The total funding available is approximately $3.15 million, with nine awards anticipated, each capped at $350,000 for a maximum duration of two years. Interested applicants must submit a pre-application by June 12, 2025, followed by full applications due by September 11, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
DoD Breast Cancer Era of Hope Scholar Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program's Era of Hope Scholar Award, aimed at early-career scientists with the potential to innovate in breast cancer research. This grant program, with an estimated total funding of approximately $10.85 million, will support two awards, each capped at $3.5 million for a maximum term of four years. The award emphasizes the importance of innovative research approaches to advance understanding and treatment of breast cancer, requiring Principal Investigators to commit at least 25% of their time to the project and to include two breast cancer consumer advocates in their research teams. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Breast Cancer Clinical Research Extension Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Breast Cancer Clinical Research Extension Award as part of the Fiscal Year 2025 Breast Cancer Research Program (BCRP). This grant aims to enhance the impact of breast cancer clinical studies by extending data collection, follow-up, and analysis, specifically addressing challenges such as early trial termination and limited patient follow-up. Approximately $26.35 million is available to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for partnered PIs, requiring the involvement of at least two breast cancer consumer advocates in the research team. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025, with successful proposals notified within six weeks post-review. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Alzheimer’s Research Program Transforming Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Alzheimer’s Research Program Transforming Care Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Dept. of the Army -- USAMRAA
The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
Alzheimer’s Research Program Transforming Diagnosis Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Diagnosis Award to support innovative research aimed at enhancing the diagnosis and prognosis of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages community collaboration and requires the submission of preliminary data, with a focus on addressing barriers to effective dementia diagnosis. With an estimated total program funding of $3.2 million, the program anticipates awarding two grants, with funding caps set at $1.5 million for single Principal Investigator (PI) proposals and $1.7 million for those utilizing the Career Initiation or Transition Partnership Option. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.